Clinical trials · Michigan
Chemotherapy-induced Peripheral Neuropathy clinical trials in Michigan
We’re tracking 3 recruiting chemotherapy-induced peripheral neuropathy studies with a site in Michigan — including Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Michigan
- NCT05642611RecruitingPhase 3
Cooling and compression for nerve protection during chemotherapy
This study tests whether using cooling and/or compression on the arms or legs can prevent nerve damage that can happen from certain chemotherapy drugs. If you get eligible chemo soon, this may help lower the chance of painful numbness or tingling during treatment.
Detroit, MichiganAges 18 years+ - NCT04633655Recruiting
Study tests nerve side effects from certain chemotherapy drugs
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
Ann Arbor, MichiganAges 18 years+ - NCT07365007Recruiting
Diet study to improve nerve pain after chemo
This study tests a diet program delivered online to help reduce nerve damage symptoms like numbness and tingling caused by chemotherapy. It is for cancer survivors who completed treatment and still have these symptoms.
Ann Arbor, MichiganAges 18 years+
Chemotherapy-induced Peripheral Neuropathy trials by city in Michigan
Where these studies are running in Michigan
Institutions with a site for the recruiting chemotherapy-induced peripheral neuropathy studies listed above.
- University of Michigan · 2 studies
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
- Henry Ford Health
- Henry Ford Macomb Hospital-Clinton Township
What taking part in a chemotherapy-induced peripheral neuropathy study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Chemotherapy-induced Peripheral Neuropathy trials in other states
Common questions
- Are there chemotherapy-induced peripheral neuropathy clinical trials in Michigan?
- Yes. We're currently tracking 3 recruiting chemotherapy-induced peripheral neuropathy studies with a site in Michigan, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a chemotherapy-induced peripheral neuropathy study in Michigan?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Michigan to take part?
- Not necessarily. These studies have a site in Michigan, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a chemotherapy-induced peripheral neuropathy trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New chemotherapy-induced peripheral neuropathy studies open in Michigan regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.